These exciting research findings provide a promising glimpse into the future of GP2’s therapeutic potential, successfully demonstrating the prospects of targeting GP2 in the treatment of autoimmune diseases and gastrointestinal disorders. The gene discussed is GP2; the disease is autoimmune disease.